FNDC5 and neoplasm: Finally, in a mouse model of glioblastoma, irisin administration resulted in increased p21 expression in conjunction with cell cycle arrest at the G2/metaphase transition, inhibited invasion via upregulation of tissue factor pathway inhibitor-2, and reduced in vivo tumor size in mice by >85% [72], thus demonstrating the strong anti-tumorigenicity of this myokine.